CAS Registry Number

CAS 38821-49-7 — Carbidopa - USP CRS

Carbidopa is a decarboxylase inhibitor used primarily in combination with levodopa to treat Parkinson’s disease, reducing peripheral side effects by preventing premature conversion of levodopa to dopamine. This USP Certified Reference Standard (CRS) features a CAS number of 38821-49-7, molecular formula C10H14N2O4·H2O, and a molecular weight of 244.24. It is stored at ambient conditions and marked with a **Warning** signal word for handling. Molekula supplies Carbidopa USP CRS from research to bulk quantities with full documentation and ISO 9001:2015 traceability.

Also known as: (2S)-2-(3,4-Dihydroxybenzyl)-2-hydrazinopropanoic acid monohydrate · (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid--water (1/1) · (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid;hydrate · (S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate · Carbidopa CRS · Carbidopa hydrate · Carbidopa RS · Carbidopa-1-wasser · Lodosyn (TN) · S-(-)-Carbidopa monohydrate · Carbidopa monohydrate